{"title": "Estimating the daily trend in the size of the COVID-19 infected population in Wuhan", "doi": "10.1101/2020.02.12.20022277", "citation_id": "2020.02.12.20022277v2", "date": "2020-02-21", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.12.20022277", "abstract": "<p>There has been an outbreak of coronavirus disease (COVID-19) in Wuhan city, Hubei province, China since December 2019. Cases have been exported to other parts of China and more than 20 countries. We provide estimates of the daily trend in the size of the epidemic in Wuhan based on detailed information of 10,940 confirmed cases outside Hubei province.</p>", "twitter_description": "There has been an outbreak of coronavirus disease (COVID-19) in Wuhan city, Hubei province, China since December 2019. Cases have been exported to other parts of China and more than 20 countries. We provide estimates of the daily trend in the size of the epidemic in Wuhan based on detailed information of 10,940 confirmed cases outside Hubei province.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNo funding.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nData retrieved from publicly available records from provincial and municipal health commissions in China and ministries of health in other countries included detailed information for 10,940 confirmed cases outside Hubei province, including region, gender, age, date of symptom onset, date of confirmation, history of travel or residency in Wuhan, and date of departure from Wuhan.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.12.20022277v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.12.20022277v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.12.20022277v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/21/2020.02.12.20022277.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.12.20022277v2", "access_rights": "restricted", "authors": ["Qiushi Lin", "Taojun Hu", "Xiao-Hua Zhou"]}